Cargando…

The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma

BACKGROUND: The genome map of hepatocellular carcinoma (HCC) is complex. In order to explore whether circulating tumor cell DNA (ctDNA) can be used as the basis for sequencing and use ctDNA to find tumor related biomarkers, we analyzed the mutant genes of ctDNA in patients with liver cancer by seque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Yubo, Yao, Jingwei, Wen, Meiling, Liu, Xiong, Huang, Jialu, Zhang, Minghui, Zhang, Yu, Lv, Yufan, Xie, Zhuoyi, Zuo, JianHong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2022
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121877/ https://www.ncbi.nlm.nih.gov/pubmed/35602894 http://dx.doi.org/10.7717/peerj.13473

Ejemplares similares

Regulating the Expression of HIF-1α or lncRNA: Potential Directions for Cancer Therapy
por: Zhang, Minghui, et al.
Publicado: (2022)

Research Progress and Direction of Novel Organelle—Migrasomes
por: Zhang, Yu, et al.
Publicado: (2022)

Application value of whole exome sequencing in screening and identifying novel mutations of hypopharyngeal cancer
por: Yao, Jingwei, et al.
Publicado: (2023)

Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19
por: Huang, Jialu, et al.
Publicado: (2022)

The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA
por: Liu, Binliang, et al.
Publicado: (2022)

MiR-139-5p influences hepatocellular carcinoma cell invasion and proliferation capacities via decreasing SLITRK4 expression
por: Wu, Jisiguleng, et al.
Publicado: (2020)

Current status of ctDNA in precision oncology for hepatocellular carcinoma
por: Li, Yan, et al.
Publicado: (2021)

Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy
por: Deng, Kun, et al.
Publicado: (2021)

Single-cell transcriptomics analysis reveals intratumoral heterogeneity and identifies a gene signature associated with prognosis of hepatocellular carcinoma
por: Liang, Jialu, et al.
Publicado: (2022)

Correction to: Current status of ctDNA in precision oncology for hepatocellular carcinoma
por: Li, Yan, et al.
Publicado: (2021)

The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review
por: Kopystecka, Agnieszka, et al.
Publicado: (2023)

Role of ctDNA in Breast Cancer
por: Sant, Marta, et al.
Publicado: (2022)

The Role of ctDNA in Gastric Cancer
por: Mencel, Justin, et al.
Publicado: (2022)

Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples
por: Gumà, Josep, et al.
Publicado: (2022)

Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis
por: Xie, Shucai, et al.
Publicado: (2019)

A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients
por: Tang, Zuxiong, et al.
Publicado: (2021)

Prognostic value and immune landscapes of immunogenic cell death-related lncRNAs in hepatocellular carcinoma
por: Chen, Wanying, et al.
Publicado: (2023)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
por: Liang, Jiaying, et al.
Publicado: (2021)

Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer
por: Oikkonen, Jaana, et al.
Publicado: (2019)

Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma
por: Wang, Sheng, et al.
Publicado: (2023)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Reliable and Scalable Identification and Prioritization of Putative Cellulolytic Anaerobes With Large Genome Data
por: Wang, Yubo, et al.
Publicado: (2022)

Comprehensive analysis of fatty acid metabolism-related gene signatures for predicting prognosis in patients with prostate cancer
por: Wang, Hongbo, et al.
Publicado: (2023)

The relationship among Girdin DNA methylation, its high expression, and immune infiltration in hepatocellular carcinoma: Clues from in silico analysis
por: Zhang, Cheng, et al.
Publicado: (2021)

DUSP12 regulates the tumorigenesis and prognosis of hepatocellular carcinoma
por: Ju, Gaoda, et al.
Publicado: (2021)

A novel DNA methylation-based model that effectively predicts prognosis in hepatocellular carcinoma
por: Hao, Xiang-Yong, et al.
Publicado: (2021)

ctDNA as a novel and promising approach for cancer diagnosis: a focus on hepatocellular carcinoma
por: Biglari, Negin, et al.
Publicado: (2023)

The association of blood ctDNA levels to mutations of marker genes in colorectal cancer
por: Bai, Fei, et al.
Publicado: (2023)

Detection of ctDNA in the plasma of patients with papillary thyroid carcinoma
por: Li, Huiqiang, et al.
Publicado: (2019)

Prognostic value of the S100 calcium-binding protein family members in hepatocellular carcinoma
por: Wei, Ran, et al.
Publicado: (2023)

Liquid Biopsy, ctDNA Diagnosis through NGS
por: Lin, Chen, et al.
Publicado: (2021)

ctDNA as a biomarker of progression in oesophageal adenocarcinoma
por: Bonazzi, V.F., et al.
Publicado: (2022)

State of the Art: ctDNA in Upper Gastrointestinal Malignancies
por: Labiano, Ibone, et al.
Publicado: (2023)

Prognostic implications of cell division cycle protein 45 expression in hepatocellular carcinoma
por: Yang, Chen, et al.
Publicado: (2021)

Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis
por: Liu, Ze-Kun, et al.
Publicado: (2019)

A dual immune signature of CD8+ T cells and MMP9 improves the survival of patients with hepatocellular carcinoma
por: Ding, Huan, et al.
Publicado: (2021)

Identification of special key genes for alcohol-related hepatocellular carcinoma through bioinformatic analysis
por: Zhang, Xiuzhi, et al.
Publicado: (2019)

Multiomics-based analyses of KPNA2 highlight its multiple potentials in hepatocellular carcinoma
por: Zhang, Jinzhong, et al.
Publicado: (2021)

Identification of hub genes and biological pathways in hepatocellular carcinoma by integrated bioinformatics analysis
por: Zhao, Qian, et al.
Publicado: (2021)

Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma
por: Zhang, Kainan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2tsmerimguji53kp6s4q6qt3s7